Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7793498 | 0.88 | — | — | |
| SCHEMBL27902176 | 0.83 | CTH (0.33) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL14742382 | 0.83 | TSHR (0.35) | TSHRSLC7A5 | |
| SCHEMBL3453970 | 0.83 | SLC7A5 (0.36) | TSHRSLC7A5 | |
| SCHEMBL11116684 | 0.82 | ALOX15 (0.33) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL31589297 | 0.81 | HCAR2 (0.35) | TSHRALOX15BLMPMP22KMT2A | |
| SCHEMBL28051778 | 0.79 | TSHR (0.39) | TSHRSLC7A5 | |
| SCHEMBL398286 | 0.79 | ALOX15 (0.52) | TSHRSLC7A5ALOX15BLMPMP22 | |
| SCHEMBL28960605 | 0.78 | ALDH1A1 (0.47) | TSHR | |
| SCHEMBL28888052 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109071616-B | Streptavidin muteins and methods of use thereof | IBA股份有限公司 | 2023-09-19 | — | — | CN | claimed |
| US-20260125614-A1 | IONIZABLE CATIONIC LIPIDS | AKAGERA MEDICINES, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12606773-B2 | Ionizable cationic lipids | AKAGERA MEDICINES, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-20260083674-A1 | OXAZOLIDINONE LIPOSOME COMPOSITIONS | AKAGERA MEDICINES, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260077038-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | AKAGERA MEDICINES, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-12577219-B2 | Macrolide brefeldin a ester derivatives and use thereof | OCEAN UNIVERSITY OF CHINA (CN) | 2026-03-17 | — | — | US | disclosed |
| US-20260069684-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | AKAGERA MEDICINES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260055335-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS | AKAGERA MEDICINES, INC. (US) | 2026-02-26 | — | — | US | disclosed |
| US-12522590-B2 | Brefeldin a derivatives, preparation method and use thereof | OCEAN UNIVERSITY OF CHINA (CN) | 2026-01-13 | — | — | US | disclosed |
| US-20260007741-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINES | AKAGERA MEDICINES, INC. (US) | 2026-01-08 | — | — | US | disclosed |
| US-20040254352-A1 | Lipid-polymer-conjugates | YAMANOUCHI EUROPE B.V. (NL) | 2004-12-16 | — | — | US | disclosed |
| US-20040241222-A1 | Lipid-polymer-conjugates compositions | ASTELLAS PHARMA EUROPE B.V. (NL) | 2004-12-02 | — | — | US | disclosed |
| EP-1392756-A2 | LIPID-POLYMER-CONJUGATES | Yamanouchi Europe B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| EP-1392755-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| CN-1135235-C | method and kit for extracting prion protein | ��������ũҵ�� | 2004-01-21 | — | — | CN | disclosed |
| WO-2002098951-A2 | LIPID-POLYMER-CONJUGATES | YAMANOUCHI EUROPE B.V. (NL) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002098952-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2002-12-12 | — | — | WO | disclosed |
| CN-1342266-A | Method and kit for extracting prion protein | US AGRICULTURE (US) | 2002-03-27 | — | — | CN | disclosed |
| CN-1230990-A | Recombination of polynucleotide sequences using random or defined primers | CALIFORNIA INST OF TECHN (US) | 1999-10-06 | — | — | CN | disclosed |
| CN-1038748-C | Method for preparing sulfonamide fibrinogen receptor antagonists | MERCK & CO INC (US) | 1998-06-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069684-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | PHOSPHO1, PLTP, SGMS1 | TSHR 4047/4885SLC7A5 117/4885ALOX15 736/4885 |
| US-20040254352-A1 | Lipid-polymer-conjugates | PARG, GLUL, PARN | TSHR 3338/4885SLC7A5 17/4885ALOX15 1412/4885 |
| US-20260007741-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINES | TLR9, TLR3, TLR8 | TSHR 3557/4885SLC7A5 1104/4885ALOX15 759/4885 |
| US-20040241222-A1 | Lipid-polymer-conjugates compositions | PHOSPHO1, PARG, GLUL | TSHR 3051/4885SLC7A5 10/4885ALOX15 2551/4885 |
| US-20260077038-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | PHOSPHO1, LNPK, SGMS2 | TSHR 3848/4885SLC7A5 122/4885ALOX15 2875/4885 |
| US-12577219-B2 | Macrolide brefeldin a ester derivatives and use thereof | BCL6, BCL6B, BCL3 | TSHR 1251/4885SLC7A5 2339/4885ALOX15 3540/4885 |
| US-20260125614-A1 | IONIZABLE CATIONIC LIPIDS | CPT2, NPC1L1, PNPLA2 | TSHR 2879/4885SLC7A5 234/4885ALOX15 237/4885 |
| US-12606773-B2 | Ionizable cationic lipids | NPC1L1, MCOLN1, SLC22A4 | TSHR 3171/4885SLC7A5 193/4885ALOX15 1321/4885 |
| US-20260055335-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS | CD4, LDLR, CD2BP2 | TSHR 664/4885SLC7A5 346/4885ALOX15 259/4885 |
| US-20260083674-A1 | OXAZOLIDINONE LIPOSOME COMPOSITIONS | TBCD, SLK, PLA2G2C | TSHR 2733/4885SLC7A5 726/4885ALOX15 3482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.